<DOC>
	<DOCNO>NCT00422721</DOCNO>
	<brief_summary>Retinal dystrophy responsible numerous case blindness , therapeutic possibility today . Gene therapy efficient dog model concern dystrophy link mutation rpe65 gene . If therapy consider human , urgent select , national level , patient suffer dystrophy link mutation rpe65 gene . The systematic correlation phenotype/genotype anatomical-functional approach , also identify patient may potentially include future gene therapy study . Indeed , identification people mutation rpe65 still insufficient France ( compare European country ) lack systemic genotyping retinal dystrophy .</brief_summary>
	<brief_title>Genetic Study Patients Suffering From Congenital Amaurosis Leber From Early Severe Retinal Dystrophy</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Blindness</mesh_term>
	<mesh_term>Retinal Dystrophies</mesh_term>
	<criteria>Patients clinical characteristic amaurosis Leber Patients suffer early severe retinal dystrophy Patients social insurance Patients consent form sign Retinal dystrophy autosomal dominant transmission Retinal dystrophy occur 5 year age Syndromical retinal dystrophy one systemic manifestation Familial macular degeneration Familial choroid dystrophy Nondegenerative retinopathology</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>early severe retinal dystrophy</keyword>
	<keyword>amaurosis leber</keyword>
</DOC>